Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Five FDA-approved drugs may help block COVID-19 virus entry.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.